Literature DB >> 30561009

Dermatology today and tomorrow: from symptom control to targeted therapy.

U Blume-Peytavi1, M Bagot2, D Tennstedt3, M Saint Aroman4, E Stockfleth5, A Zlotogorski6, V Mengeaud7, A M Schmitt8, C Paul9, H W Lim10, V Georgescu11, B Dréno12, T Nocera13.   

Abstract

For many decades and until recently, medical approach to dermatologic diseases has been based on the physician's ability to recognize and treat symptoms. Nowadays, advances in the understanding of the biology of diseases and in technologies for intervening against them have allowed physicians to diagnose and treat underlying disease processes rather than simply addressing the symptoms. This means that rather than addressing 'the disease in humans', physicians can now address the particular pathologic (biologic, molecular) disturbance as it presents in the individual patient, i.e., physicians now can practice something much closer to 'personalized medicine', leading to greater benefits for the patients and the health of society in general. The deeper understanding of ultraviolet radiation, the importance of photoprotection and increased knowledge about signalling pathways of melanoma and carcinoma have led to more complete care for the dermatologic patient. The current popularity for excessive exposure to the sun, without adequate application of the appropriate photoprotection remedies, is the origin of melanoma, but also for the weakening of the structure and functions of the skin. Indeed, fragility of the skin can affect humans around the world. In the senior population, this skin fragility is accompanied by pruritus, whereas atopic dermatitis is an inflammatory disease with highest prevalence in children and adolescents. Acne, the number one reason for dermatologic consultations worldwide, increases its prevalence in adolescents and in females. Senescent alopecia affects humans after menopause and andropause. The articles in this publication present an overview of the current advanced understanding of the diagnosis and therapeutic approaches in 6 fields of dermatology - dermatopaediatry and gerontodermatology, oncodermatology, hair loss, atopic dermatitis, photoprotection and acne - and thereby serve as a useful compendium of updated information and references for all healthcare professionals who see patients with presentations of the symptoms of these diseases.
© 2018 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30561009     DOI: 10.1111/jdv.15335

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  5 in total

Review 1.  Experimental Drugs with the Potential to Treat Atopic Eczema.

Authors:  Kam Lun Ellis Hon; Vivian P Y Chan; Alexander K C Leung
Journal:  J Exp Pharmacol       Date:  2021-05-12

2.  In Vivo Evaluation of the Anti-Inflammatory Activity of Electrospun Micro/Nanofibrous Patches Loaded with Pinus halepensis Bark Extract on Hairless Mice Skin.

Authors:  Eleftheria Kotroni; Eleftheria Simirioti; Stefanos Kikionis; Ioannis Sfiniadakis; Aggeliki Siamidi; Vangelis Karalis; Andreas Vitsos; Marilena Vlachou; Efstathia Ioannou; Vassilios Roussis; Michail Rallis
Journal:  Materials (Basel)       Date:  2019-08-15       Impact factor: 3.623

3.  The Effect of Biological Agents on Antinuclear Antibody Status in Patients with Psoriasis: A Single-Center Study.

Authors:  Ömer Kutlu; Pınar Çetinkaya; Tijen Şahin; Hatice Meral Ekşioğlu
Journal:  Indian Dermatol Online J       Date:  2020-11-08

4.  Study on the Molecular Basis of Huanglian Jiedu Decoction Against Atopic Dermatitis Integrating Chemistry, Biochemistry, and Metabolomics Strategies.

Authors:  Jing Chen; Saizhen Chen; Jinguang Chen; Bixin Shen; Zhengli Jiang; Yubin Xu
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

Review 5.  From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine.

Authors:  Laura Maintz; Thomas Bieber; Helen D Simpson; Anne-Laure Demessant-Flavigny
Journal:  J Pers Med       Date:  2022-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.